key: cord-0741056-74i2tn87 authors: Jalaber, Carole; Lapotre, Thibaut; Morcet-Delattre, Thibaud; Ribet, Félix; Jouneau, Stéphane; Lederlin, Mathieu title: Chest CT in COVID-19 pneumonia: a review of current knowledge date: 2020-06-11 journal: Diagn Interv Imaging DOI: 10.1016/j.diii.2020.06.001 sha: 045d35854a4f92e409d47b7fb5598dec1a877112 doc_id: 741056 cord_uid: 74i2tn87 Abstract The current COVID-19 pandemic has highlighted the essential role of chest computed tomography (CT) examination in patient triage in the emergency departments, allowing them to be referred to "COVID" or "non-COVID" wards. Initial chest CT examination must be performed without intravenous administration of iodinated contrast material, but contrast material administration is required when pulmonary embolism is suspected, which seems to be frequent in severe forms of the disease. Typical CT features consist of bilateral ground-glass opacities with peripheral, posterior and basal predominance. Lung disease extent on CT correlates with clinical severity. Artificial intelligence could assist radiologists for diagnosis and prognosis evaluation. By June 8, 2020 , the COVID-19 pandemic had affected more than 6.9 million people worldwide, resulting in 401,970 deaths (1). The most typical clinical presentation of COVID-19 is an acute febrile respiratory infection with dry cough, dyspnea, fatigue and myalgia. Approximately 15-20% of patients have severe disease and the mortality is around 2-3% (2) (3) (4) . In the absence of vaccine or specific therapy available to date, it is essential to be able to diagnose this disease as early as possible in order to isolate infected subjects and thus limit the spread of the disease. The method of reference is laboratory testing of nasopharyngeal aspirates for identification of SARS-CoV-2 by reverse transcriptase -polymerase chain reaction (RT-PCR). However, it takes several hours to obtain the results, and the sensitivity of the test is only 60 to 70%, depending on the quality of the sample and the rate of viral replication in the upper respiratory tract (5, 6) . Chest computed tomography (CT) has rapidly emerged as a rapid and effective diagnostic tool, given the often quite characteristic presentation of COVID-19 pneumonia (7, 8) . Now that the J o u r n a l P r e -p r o o f 3 "first wave" has passed and the pandemic appears to be under control, we propose to review and update the current knowledge on COVID-19 pneumonia imaging. The massive arrival of patients suspected of having COVID-19 in emergency departments has prompted the setting up of "COVID" and "non COVID" pathways, making it necessary to triage patients as early as possible. According to the ESR/ESTI advice paper and recommendations of the French Society of Thoracic Imaging, unenhanced chest CT is currently indicated for patients presenting with dyspnea, polypnea or desaturation in order to refer them to "COVID" or "non COVID" wards, pending RT-PCR results (9) . Chest CT sensitivity for the diagnosis of COVID-19 is greater than 90%, with false-negative findings mostly in patients who are symptomatic for less than 3 days (5, 10) . CT specificity is more variable. Series from China and Italy reported specificity values between 25% and 56% (5, 11) . A meta-analysis, including mainly Asian studies, reported pooled sensitivity and specificity of 94% and 37% respectively for the diagnosis of COVID-19 pneumonia (12) . Furthermore, this meta-analysis reported a high degree of variability in positive predictive value of chest CT according to prevalence. Depending on whether the prevalence is 1%, 10% or 39%, the positive predictive value would become 1.5%, 14.2% or 48.8%, respectively. Thus, the use of CT as a screening tool in low prevalence areas would lead to a large number of false positives. In addition, it should be noted that inter-reader agreement of chest CT for COVID-19 diagnosis is generally reported to be good or even excellent (13, 14) . In practice, chest CT results can lead to three scenarios: (i) when chest CT is very suggestive of COVID-19, the patient will be hospitalized in a COVID-19 isolation ward, and RT-PCR testing will generally confirm the diagnosis; (ii) when chest CT shows an obvious alternate diagnosis (e.g. bacterial lobar pneumonia or left ventricular failure), the patient will be hospitalized in a "non COVID-19" ward; (iii) when chest CT scan is indeterminate, RT-PCR testing along with clinical symptoms will be essential for referral to the most appropriate ward. Chest CT scans should not be performed for screening purpose in asymptomatic patients. Neither chest X-ray nor ultrasonography is recommended for the diagnosis of COVID-19, as their performance appears to be significantly inferior to that of CT. The most typical CT features of COVID-19 pneumonia are bilateral and multifocal groundglass opacities. Lesions classically predominate in the peripheral, posterior and basal part of the lungs (Figure 1 ) (10) . Other signs have been reported such as the presence of fine reticulations, peribronchovascular thickening, vascular dilatations within pneumonia areas, or architectural distortion (15) . Usually, there are no micronodules, excavations, septal lines, mediastinal lymph node enlargement or pleural effusions. Some infected but asymptomatic patients may have slight ground-glass opacities but these are generally not extensive (16) . However, the peripheral location of the lesions, involvement of the five lobes, the presence of thin reticulations and peribronchovascular thickening would be more frequently found in COVID-19 pneumonitis (17, 18) . In influenza pneumonia, nodular or micronodular tree-in-bud pattern may be more common, as may pleural effusions (19) . In approximately 10% of patients, lung involvement of COVID-19 may present as arciform or pseudonodular consolidation suggesting a pattern of organizing pneumonia (20) , sometimes with a "reverse halo sign" similar to the one observed in other infectious diseases (21) . Unilateral presentation is possible in about 20-30% of patients, usually at an early stage before bilateralization of the lesions (5, 22) . Peribronchovascular or apical predominance is also described ( Figure 3 ) (23) . When COVID-19 pneumonia occurs in a previously abnormal lung (e.g., with underlying emphysema or fibrosis), CT presentation becomes less specific, making a careful comparison with previous CT examinations, when available, mandatory ( Figure 4) (24). Ground-glass opacities tend to progress over time, both in extent and attenuation value, and evolve either towards crazy paving areas (i.e. superimposition of ground-glass and intralobular reticulations), or towards linear and retractile consolidation areas ( Figure 2 ) (10, (25) (26) (27) . Lung damage is maximal around day 10 and then generally decreases progressively in size and attenuation value (28). However, early available data on the late appearance of lung parenchyma are still scarce. While complete resolution seems to be common in patients with mild pneumonia, it seems that many patients, especially those with initial severe disease, still present reticular pattern of fibrotic streaks after more than one month of evolution ( Figure 2 ). According to a recent study, lung abnormalities could persist beyond one month in 98% of patients (29). There is therefore some concern about a significant number of pulmonary fibrotic sequelae, although the proportion is not yet known (15, 26) . The total extent of lung involvement on the first CT examination is correlated with clinical severity (13, 25, 30) . The French Society of Thoracic Imaging (SIT) recommends grading lung involvement as absent or minimal (<10%), moderate (10-25%), extensive (25-50%), severe (50-75%) or critical (>75%) ( Figure 5 ). The density of pulmonary lesions is also a marker of severity, since lung consolidation areas appear more extensive than ground-glass opacities in critically ill patients (30). Pleural effusion and early architectural distortion with traction bronchiectasis on initial chest CT would also indicate a poor prognosis (15) . A Chinese series suggests that consolidation in upper lobes on initial CT is also associated with poor outcomes (31). Between 15 and 30% of hospitalized patients progress to acute respiratory distress syndrome (ARDS), which is the main cause of mortality in COVID-19. ARDS is characterized in CT by extensive bilateral lung consolidation with a predominance in dependent areas ( Figure 5 ) (4, 32) . In addition, several complications can occur in the clinical course of these patients. Pulmonary bacterial superinfection will be suspected in case of additional alveolar consolidation areas with pleural effusion and/or enlarged lymph nodes (15) . In a recent study, COVID-19 associated pulmonary aspergillosis was reported in 5 of 19 consecutive patients with ARDS( Figure 6 ) (33) . However, distinction between COVID-19 and pulmonary aspergillosis lesions with CT remains difficult (34) . Pulmonary embolism has been reported in COVID-19 patients (Figure 7 ) (35) (36) (37) (38) . In critically ill patients, there is an exacerbated systemic inflammatory response leading to an hypercoagulability state, reflected by the marked increase of D-dimer serum level in these patients (39) . The occurrence of pulmonary embolism is mainly reported in intensive care unit patients, based on retrospective studies. The exact prevalence of pulmonary embolism in COVID19 remains unknown, and would require a prospective evaluation, with systematic assessment of clinical symptoms, CT features and D-dimers. Routine CT pulmonary angiography to check for pulmonary embolism is so far not indicated as a first-line diagnostic tool. However, a clinical-radiological discordance (dyspnea and hypoxemia without lung abnormality) or respiratory worsening in a known COVID-19 patient should prompt the use of contrast medium injection. It would be worth assessing the value of routine CT pulmonary angiography in patients with highly elevated D-dimer levels. Finally, radiologists should be aware that pulmonary infarction secondary to pulmonary embolism may be quite similar in appearance to COVID-19 pneumonia (Figure 8 ). In the pediatric population, pulmonary CT involvement is often less extensive than in adults. There are often no CT abnormalities (40) . In case of lung involvement, ground-glass is the predominant sign (40, 41) . The "halo sign" is found more frequently than in adults (39, 41) . Coinfections, especially viral, are also more frequent (42) . specific per or post-partum complications (43) . Consolidation might be more common than in the general population (44) . There appears to be no excess mortality related to COVID-19 in pregnant women (45) . Machine learning techniques have the potential to dramatically transform medical imaging (46) (47) (48) (50) . identifying biomarkers predictive of patient outcomes. For this purpose, several national and international databases are currently being deployed to enable AI models to be trained on massive data. Characteristics of and Important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Clinical characteristics of coronavirus disease 2019 in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases Sensitivity of chest CT for COVID-19: comparison to RT-PCR Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19) COVID-19 pneumonia: a review of typical CT findings and differential diagnosis COVID-19 patients and the radiology department -advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Chest CT features of COVID-19 in Diagnostic performance of CT and reverse transcriptasepolymerase chain reaction for coronavirus disease 2019: a meta-analysis Chest CT severity score: an imaging tool for assessing severe COVID-19 Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study Chest CT findings in cases from the cruise ship "Diamond Princess Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT Comparison of chest CT findings between COVID-19 pneumonia and other types of viral pneumonia: a two-center retrospective study COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia Reversed halo sign » on 3D CT in COVID-19 Nodular reverse halo sign in active pulmonary tuberculosis: a rare CT feature? Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study CT imaging features of 2019 novel coronavirus (2019-nCoV) CT features of pulmonary interstitial emphysema Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study Evolution of CT findings in patients with mild COVID-19 pneumonia Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China COVID-19 associated pulmonary aspergillosis COVID-19-associated invasive pulmonary aspergillosis Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence Pulmonary embolism in patients with Covid-19 pneumonia Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Clinical features of pediatric patients with coronavirus disease (COVID-19) Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: a review Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults What are the risks of COVID-19 infection in pregnant women? Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes Impact of the rise of artificial intelligence in radiology: what do radiologists think? Convolutional neural network evaluation of over-scanning in lung computed tomography Artificial intelligence distinguishes COVID-19 from community-acquired pneumonia on chest CT Serial quantitative chest CT assessment of COVID-19: deep-learning approach The authors declare that they have no competing interest. All authors attest that they meet the current International Committee of Medical Journal Editors (ICMJE) criteria for Authorship. The authors declare that this report does not contain any personal information that could lead to the identification of the patients.